XTL Biopharmaceuticals Ltd (XTLB)
2.65
-0.09
(-3.28%)
USD |
NASDAQ |
May 16, 16:00
2.47
-0.18
(-6.79%)
After-Hours: 06:35
XTL Biopharmaceuticals Enterprise Value: 12.10M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 12.10M |
| May 15, 2024 | 12.59M |
| May 14, 2024 | 11.67M |
| May 13, 2024 | 13.57M |
| May 10, 2024 | 11.61M |
| May 09, 2024 | 10.74M |
| May 08, 2024 | 11.01M |
| May 07, 2024 | 11.56M |
| May 06, 2024 | 11.45M |
| May 03, 2024 | 11.45M |
| May 02, 2024 | 11.42M |
| May 01, 2024 | 11.83M |
| April 30, 2024 | 11.77M |
| April 29, 2024 | 10.85M |
| April 26, 2024 | 10.86M |
| April 25, 2024 | 10.74M |
| April 24, 2024 | 11.61M |
| April 23, 2024 | 11.77M |
| April 22, 2024 | 12.10M |
| April 19, 2024 | 10.96M |
| April 18, 2024 | 10.96M |
| April 17, 2024 | 11.12M |
| April 16, 2024 | 11.83M |
| April 15, 2024 | 12.26M |
| April 12, 2024 | 11.83M |
| Date | Value |
|---|---|
| April 11, 2024 | 12.70M |
| April 10, 2024 | 12.81M |
| April 09, 2024 | 14.99M |
| April 08, 2024 | 14.83M |
| April 05, 2024 | 15.43M |
| April 04, 2024 | 14.61M |
| April 03, 2024 | 15.81M |
| April 02, 2024 | 13.03M |
| April 01, 2024 | 14.06M |
| March 28, 2024 | 13.31M |
| March 27, 2024 | 12.71M |
| March 26, 2024 | 14.72M |
| March 25, 2024 | 13.31M |
| March 22, 2024 | 12.27M |
| March 21, 2024 | 11.18M |
| March 20, 2024 | 10.96M |
| March 19, 2024 | 3.661M |
| March 18, 2024 | 4.309M |
| March 15, 2024 | 2.789M |
| March 14, 2024 | 2.811M |
| March 13, 2024 | 3.171M |
| March 12, 2024 | 3.225M |
| March 11, 2024 | 3.225M |
| March 08, 2024 | 3.007M |
| March 07, 2024 | 2.626M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.100M
Minimum
Mar 27 2020
21.17M
Maximum
Sep 02 2021
6.321M
Average
4.208M
Median
Apr 03 2023
Enterprise Value Benchmarks
| Compugen Ltd | 140.91M |
| Pluri Inc | 34.05M |
| BioLine Rx Ltd | 18.09M |
| Can Fite Biofarma Ltd | 2.244M |
| BiomX Inc | 14.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.485M |
| Total Expenses (Quarterly) | 0.175M |
| EPS Diluted (Quarterly) | 0.10 |
| Earnings Yield | -1.18% |
| Normalized Earnings Yield | -19.64 |